Issued Patents All Time
Showing 25 most recent of 73 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12427157 | Methods for treatment of diseases involving acidic or hypoxic diseased tissues | Daniel Richard Marshall, Johanna Marie Csengery, Dalton King, Yana K. Reshetnyak, Oleg A. Andreev +1 more | 2025-09-30 |
| 12410262 | Peptide conjugates of cytotoxins as therapeutics | Daniel Richard Marshall, Johanna Marie Csengery, Robert John Maguire | 2025-09-09 |
| 12358929 | NMDA receptor modulators and uses thereof | David R. Anderson, Frank S. Menniti, Christopher Fanger, Yuelian Xu | 2025-07-15 |
| 12234212 | Peptide conjugates of microtubule-targeting agents as therapeutics | Daniel Richard Marshall, Johanna Marie Csengery, Robert John Maguire | 2025-02-25 |
| 12162890 | Heteroaromatic NMDA receptor modulators and uses thereof | David R. Anderson, Frank S. Menniti, Christopher Fanger | 2024-12-10 |
| 12161624 | Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B | David R. Anderson, Frank S. Menniti | 2024-12-10 |
| 12145909 | N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[C]pyrrole negative allosteric modulators of NR2B | David R. Anderson, Frank S. Menniti | 2024-11-19 |
| 11866444 | Oxabicycloheptane prodrugs | John S. Kovach, Anthony Marfat | 2024-01-09 |
| 11807650 | NMDA receptor modulators and uses thereof | David R. Anderson, Frank S. Menniti, Christopher Fanger, Yuelian Xu | 2023-11-07 |
| 11648253 | Thienopyrimidinone NMDA receptor modulators and uses thereof | David R. Anderson, Frank S. Menniti, Christopher Fanger | 2023-05-16 |
| 11634508 | Peptide conjugates of cytotoxins as therapeutics | Daniel Richard Marshall, Johanna Marie Csengery, Robert John Maguire | 2023-04-25 |
| 11555019 | Peptide conjugates of microtubule-targeting agents as therapeutics | Daniel Richard Marshall, Johanna Marie Csengery, Robert John Maguire | 2023-01-17 |
| 11541057 | Thienopyrimidinone NMDA receptor modulators and uses thereof | David R. Anderson, Frank S. Menniti, Christopher Fanger | 2023-01-03 |
| 11542264 | Heteroaromatic NMDA receptor modulators and uses thereof | David R. Anderson, Gregg F. Keaney, Steven C. Leiser, Sam Malekiani, Timothy Piser | 2023-01-03 |
| 11274107 | NMDA receptor modulators and uses thereof | David R. Anderson, Frank S. Menniti, Christopher Fanger, Yuelian Xu | 2022-03-15 |
| 11236104 | Heteroaromatic NMDA receptor modulators and uses thereof | David R. Anderson, Frank S. Menniti, Christopher Fanger | 2022-02-01 |
| 11236102 | Oxabicycloheptane prodrugs | John S. Kovach, Anthony Marfat | 2022-02-01 |
| 11116749 | Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B | David R. Anderson, Frank S. Menniti | 2021-09-14 |
| 10973825 | Thienopyrimidinone NMDA receptor modulators and uses thereof | David R. Anderson, Frank S. Menniti, Christopher Fanger | 2021-04-13 |
| 10933069 | Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues | Daniel Richard Marshall, Johanna Marie Csengery, Dalton King, Yana K. Reshetnyak, Oleg A. Andreev +1 more | 2021-03-02 |
| 10781174 | N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[C]pyrrole negative allosteric modulators of NR2B | David R. Anderson, Frank S. Menniti | 2020-09-22 |
| 10752633 | Heteroaromatic NMDA receptor modulators and uses thereof | David R. Anderson, Gregg F. Keaney, Steven C. Leiser, Sam Malekiani, Timothy Piser | 2020-08-25 |
| 10626122 | Heteroaromatic NMDA receptor modulators and uses thereof | David R. Anderson, Frank S. Menniti, Christopher Fanger | 2020-04-21 |
| 10618908 | Oxabicycloheptane prodrugs | John S. Kovach, Anthony Marfat | 2020-04-14 |
| 10584131 | Heteroaromatic NMDA receptor modulators and uses thereof | David R. Anderson, Gregg F. Keaney, Steven C. Leiser, Sam Malekiani, Timothy Piser | 2020-03-10 |